Report of Foreign Issuer (6-k)
May 31 2016 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
May 31, 2016
Commission File Number:
333-196065
Parnell Pharmaceuticals Holdings Ltd
(Translation of registrant's name into English)
Unit 4, Century Estate
476 Gardeners Road
Alexandria 2015 NSW
Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
On May 31, 2016, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(c) Exhibit 99.1. Press release dated May 31, 2016
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
Parnell Pharmaceuticals Holdings Ltd
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date: May 31, 2016
|
|
/s/ Robert Joseph
|
|
|
Robert Joseph
|
|
|
President and CEO
|
|
|
|
Parnell Pharmaceuticals (CE) (USOTC:PARNF)
Historical Stock Chart
From Jul 2024 to Aug 2024
Parnell Pharmaceuticals (CE) (USOTC:PARNF)
Historical Stock Chart
From Aug 2023 to Aug 2024